AAPS National Biotechnology Conference
May 11–14, 2026, San Diego, USA
Coriolis Pharma will be present at the AAPS National Biotechnology Conference (NBC) 2026, a scientific meeting dedicated to the latest advances shaping modern biotherapeutic development. The conference highlights emerging technologies, novel modalities, and new strategies that are redefining how biologics and advanced therapies move from research to clinical application.
Through presentations, posters, and technical discussions, NBC explores topics spanning formulation innovation, bioanalytical science, and bioprocessing approaches for increasingly complex therapeutic modalities.
For teams working on biologics, RNA-based medicines, or next-generation therapeutic platforms, the conference offers a valuable setting to exchange perspectives on development challenges and emerging solutions.
Coriolis Pharma will be on site in San Diego and welcomes the opportunity to continue these conversations with partners across the biopharma community.
